Can I run multiple peptide cycles per year?
Yes — 2-4 cycles per year is typical. Plan real rest periods between, run annual labs, and watch cumulative exposure on IGF-1 LR3 and long-acting GH.
Updated May 8, 2026 · 6 min read
Yes — 2-4 peptide cycles per year is typical for many strength-peptide users. The structure that matters: real off periods between cycles, an annual extended break (8-12 weeks), and annual bloodwork to catch drift. The cumulative-exposure question is more important than any single cycle, especially for IGF-1 LR3 and long-acting GH peptides. What you can't do safely is back-to-back cycles with mini-breaks and no monitoring.
The annual planning question is one of the more useful framings in the strength-peptide space. Single cycles are easy to plan; the year is where the real protocol lives.
What 2-4 cycles per year actually looks like
A realistic annual layout depends on which peptides you're running:
| Profile | Typical year |
|---|---|
| Recovery-focused (BPC-157 / TB-500) | 2-3 cycles of 6-8 weeks, aligned with training blocks or injury windows |
| GH secretagogue (Ipa+CJC no-DAC) | 2 cycles of 12-16 weeks with 8 weeks off between; one annual extended break |
| Mixed recovery + GH | 1 GH-stack cycle + 1-2 shorter recovery cycles in the off period; 8+ week annual break |
| MK-677 | 2 cycles of 8-12 weeks with 8 weeks off; annual extended break |
| IGF-1 LR3 | Maximum 3-4 short cycles per year (4-6 weeks each); 4-8 weeks off between; annual extended break |
| MOTS-c | 2 cycles of 8-12 weeks |
| Topical GHK-Cu | Continuous use; injectable cycles separately |
The "more than 4 cycles" pattern starts to compress off periods below the recovery threshold, and at that point you're functionally on continuous cycling. See should I cycle peptides forever.
Plan around training, not the calendar
Cycles should serve goals, and goals usually map to training blocks. A reasonable annual planning approach:
| Cycle | Timing | Goal |
|---|---|---|
| Cycle 1 | Aligned with first heavy training block | Recovery / GH support during accumulation |
| Off period | Deload / lighter training | Reassess; bloodwork |
| Cycle 2 | Second training block | Repeat or pivot based on cycle 1 |
| Annual extended break | 8-12 weeks | Full recovery; full bloodwork; honest reassessment |
| Cycle 3-4 | Remaining training blocks | Goal-specific |
Calendar-driven cycling ("I always run a cycle in January") tends to drift goal-free. Training-driven cycling has built-in reassessment.
For more, see seasonal cycling.
Cumulative-exposure considerations
The cycles-per-year question matters most for peptides where exposure accumulates:
| Peptide class | Cumulative concern | Mitigation |
|---|---|---|
| IGF-1 LR3 | Cancer-axis caveats compound with total exposure | Limit to 2-3 short cycles per year; annual labs |
| Long-acting GH (CJC DAC) | Receptor desensitization; metabolic drift | Limit to 2 cycles per year; 8+ week off periods |
| MK-677 | Insulin sensitivity drift can persist | Annual HbA1c + fasting glucose; longer off periods if drift |
| Recovery peptides | Theoretical angiogenic-signaling concerns | 8+ week annual break; reassess overall exposure |
The honest framing for IGF-1 LR3 specifically: each cycle is a defined exposure period. Total exposure across a year is the sum. People who run aggressive multi-cycle IGF-1 LR3 protocols are accepting higher total exposure than people who run one or two cycles. Whether that's reasonable depends on goals, age, family cancer history, and clinician input.
For more on the cancer-axis caveats, see peptides and cancer history (where cancer history is covered) and IGF-1 LR3 cycle length.
The annual labs framework
If you're running multiple cycles per year, annual labs aren't optional. Reasonable defaults:
| Lab | Frequency | Why |
|---|---|---|
| Fasting glucose | Each cycle (start + end) | Insulin sensitivity drift on secretagogues |
| HbA1c | Each cycle or twice yearly | Longer-term glucose trend |
| Lipid panel | Annual | Cardiovascular drift |
| Liver enzymes (ALT, AST) | Annual | Liver stress |
| Kidney function (creatinine, BUN) | Annual | Kidney stress |
| IGF-1 | Each secretagogue cycle | GH-axis activity confirmation |
| CBC | Annual | Blood cell counts |
| Basic metabolic panel | Annual | Electrolyte and kidney baseline |
| PSA (men 40+) | Annual | Standard health screening; relevant if running IGF-1-elevating peptides |
Lab work is cheap relative to peptide cycles. Run it.
For more, see peptides and bloodwork.
The annual extended break
The single most useful structural addition for chronic cyclers: an 8-12 week annual extended break where everything is off.
What this accomplishes:
- Receptor recovery — even short-acting peptides benefit from a full reset window
- Honest reassessment — without peptides on board, you find out what your baseline actually is
- Side-effect detection — drift symptoms that were rationalized as "normal" sometimes resolve, revealing the peptide as the cause
- Metabolic recovery — fasting glucose, HbA1c, and IGF-1 can return toward baseline
- Protocol audit — is what you're doing still serving the original goal?
A good time for the annual break: aligned with a deload, post-competition, end of a season, or just a chosen window like late summer.
Cycle stacking across the year
The mistake to avoid: treating "stopping one peptide" as the end of the cycle when you immediately start another.
| Pattern | Is it really cycling? |
|---|---|
| BPC-157 cycle ends, immediately start GH-secretagogue cycle | No — that's continuous peptide use with rotating compounds |
| GH secretagogue ends, 4 weeks off, then BPC-157 cycle | Yes — there's a true off period |
| Multiple peptides simultaneously, then full off period | Yes — that's a stack with a real cycle |
| Always running something | No — that's continuous use with extra steps |
Off period means zero peptide on board. Substituting another peptide isn't a recovery period; it's continuous use with a different mechanism in the foreground.
Budget reality
A multi-cycle year adds up. Rough framing for a typical year:
| Profile | Annual budget |
|---|---|
| 2 BPC-157 cycles | $200-500 |
| 2 BPC + TB-500 stack cycles | $600-1200 |
| 2 GH secretagogue cycles (Ipa+CJC no-DAC) | $500-1000 |
| Mixed recovery + GH year | $800-1500 |
| Aggressive multi-peptide cyclers | $2000-4000+ |
Plus annual bloodwork: $200-600 depending on insurance and panel.
Cycles without monitoring are riskier than not cycling. If the budget can fit cycles but not labs, run fewer cycles.
A reasonable annual framework
For the typical multi-cycle user:
- Plan the year around training blocks, not the calendar
- 2-4 cycles is the realistic range for most users
- Real off periods between cycles — at least 4-8 weeks, longer for long-acting peptides
- Annual extended break — 8-12 weeks where everything is off
- Annual labs — non-negotiable if you're running this many cycles
- Per-cycle goals — no goal, no cycle
- Annual protocol audit — is the year actually moving you toward your goals, or is it cycling for its own sake?